|View printer-friendly version|
|November 07, 2003 4:49 p.m.|
|Teva Announces Tentative Approval Of Benazepril Hcl Tablets, 5 Mg, 10 Mg, 20 Mg, And 40 Mg|
Jerusalem, Israel, November 7, 2003 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the company's ANDA for Benazepril Hydrochloride Tablets, 5 mg, 10 mg, 20 mg and 40 mg. Final approval is anticipated upon expiry of pediatric exclusivity, which protects the brand product until February 11, 2004.